Cardiff Oncology PE Ratio 2012-2024 | CRDF

Current and historical p/e ratio for Cardiff Oncology (CRDF) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cardiff Oncology PE ratio as of October 11, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Cardiff Oncology PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-10-11 2.63 0.00
2024-06-30 2.22 $-0.91 0.00
2024-03-31 5.34 $-0.90 0.00
2023-12-31 1.48 $-0.93 0.00
2023-09-30 1.39 $-0.92 0.00
2023-06-30 1.47 $-0.90 0.00
2023-03-31 1.65 $-0.89 0.00
2022-12-31 1.40 $-0.89 0.00
2022-09-30 1.54 $-0.92 0.00
2022-06-30 2.20 $-0.89 0.00
2022-03-31 2.48 $-0.82 0.00
2021-12-31 6.01 $-0.71 0.00
2021-09-30 6.66 $-0.67 0.00
2021-06-30 6.65 $-0.69 0.00
2021-03-31 9.26 $-1.03 0.00
2020-12-31 17.99 $-0.89 0.00
2020-09-30 14.19 $-1.21 0.00
2020-06-30 5.01 $-1.73 0.00
2020-03-31 1.01 $-2.01 0.00
2019-12-31 1.24 $-3.03 0.00
2019-09-30 1.51 $-3.61 0.00
2019-06-30 2.50 $-3.98 0.00
2019-03-31 3.75 $-8.47 0.00
2018-12-31 3.15 $-13.93 0.00
2018-09-30 4.89 $-17.16 0.00
2018-06-30 4.62 $-24.72 0.00
2018-03-31 25.14 $-38.17 0.00
2017-12-31 22.14 $-54.73 0.00
2017-09-30 52.56 $-74.90 0.00
2017-06-30 90.72 $-90.74 0.00
2017-03-31 82.80 $-96.50 0.00
2016-12-31 151.20 $-99.38 0.00
2016-09-30 323.28 $-93.62 0.00
2016-06-30 326.16 $-85.70 0.00
2016-03-31 334.80 $-90.74 0.00
2015-12-31 388.80 $-88.58 0.00
2015-09-30 409.68 $-87.86 0.00
2015-06-30 730.80 $-91.46 0.00
2015-03-31 490.32 $-66.25 0.00
2014-12-31 309.60 $-54.73 0.00
2014-09-30 329.76 $-40.33 0.00
2014-06-30 252.00 $-38.17 0.00
2014-03-31 412.56 $-58.33 0.00
2013-12-31 413.28 $-51.13 0.00
2013-09-30 516.96 $-78.50 0.00
2013-06-30 503.28 $-64.09 0.00
2013-03-31 450.72 $-59.77 0.00
2012-12-31 498.96 $-54.73 0.00
2012-09-30 255.60 $-32.41 0.00
2012-06-30 280.80 $-28.81 0.00
2012-03-31 315.36 $-8.64 0.00
2011-12-31 237.60 $-8.64 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.122B $0.000B
Cardiff Oncology Inc. is a clinical-stage biotechnology company. It engages in developing treatment for cancer patients. The company's product pipeline consists of a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin(R) in KRAS-mutated metastatic colorectal cancer; a Phase 2 study of onvansertib in combination with Zytiga(R) in Zytiga-resistant metastatic castration-resistant prostate cancer; and a Phase 2 study of onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Cardiff Oncology Inc., formerly known as Trovagene Inc., is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $176.432B 17.65
Vertex Pharmaceuticals (VRTX) United States $124.330B 0.00
Regeneron Pharmaceuticals (REGN) United States $111.962B 26.44
Bristol Myers Squibb (BMY) United States $105.830B 38.10
Gilead Sciences (GILD) United States $105.762B 18.07
CSL (CSLLY) Australia $97.025B 0.00
GSK (GSK) United Kingdom $80.476B 9.33
Alnylam Pharmaceuticals (ALNY) United States $36.501B 0.00
Argenex SE (ARGX) Netherlands $32.093B 0.00
BioNTech SE (BNTX) Germany $28.656B 0.00
Biogen (BIIB) United States $27.440B 11.59
Illumina (ILMN) United States $23.185B 158.20
BeiGene (BGNE) Cayman Islands $22.982B 0.00
Moderna (MRNA) United States $22.406B 0.00
Genmab (GMAB) Denmark $15.571B 19.45
BioMarin Pharmaceutical (BMRN) United States $13.358B 39.52
Exact Sciences (EXAS) United States $13.111B 0.00
Insmed (INSM) United States $12.813B 0.00
Vaxcyte (PCVX) United States $12.770B 0.00
Incyte (INCY) United States $12.735B 826.50
Sarepta Therapeutics (SRPT) United States $11.874B 270.67
Bio-Techne Corp (TECH) United States $11.638B 45.56
QIAGEN (QGEN) Netherlands $10.023B 21.16
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Legend Biotech (LEGN) United States $9.115B 0.00
Roivant Sciences (ROIV) United Kingdom $8.800B 0.00
Revolution Medicines (RVMD) United States $8.432B 0.00
Intra-Cellular Therapies (ITCI) United States $8.005B 0.00
Ascendis Pharma (ASND) Denmark $7.815B 0.00
Repligen (RGEN) United States $7.775B 118.65
Exelixis (EXEL) United States $7.482B 23.01
Viking Therapeutics (VKTX) United States $7.295B 0.00
Halozyme Therapeutics (HALO) United States $6.714B 17.67
Nuvalent (NUVL) United States $6.712B 0.00
Cytokinetics (CYTK) United States $6.457B 0.00
Zealand Pharma (ZLDPF) Denmark $5.891B 0.00
Blueprint Medicines (BPMC) United States $5.626B 0.00
Krystal Biotech (KRYS) United States $5.134B 343.67
Avidity Biosciences (RNA) United States $5.117B 0.00
Biohaven (BHVN) United States $5.080B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.078B 0.00
Alkermes (ALKS) Ireland $4.761B 16.71
Arcellx (ACLX) United States $4.634B 0.00
Immunovant (IMVT) United States $4.450B 0.00
Axsome Therapeutics (AXSM) United States $4.159B 0.00
Denali Therapeutics (DNLI) United States $4.009B 0.00
ADMA Biologics Inc (ADMA) United States $3.996B 65.94
CRISPR Therapeutics AG (CRSP) Switzerland $3.984B 0.00
Merus (MRUS) Netherlands $3.642B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.397B 0.00
Apellis Pharmaceuticals (APLS) United States $3.305B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.126B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.122B 0.00
Amicus Therapeutics (FOLD) United States $3.114B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.046B 0.00
Edgewise Therapeutics (EWTX) United States $2.993B 0.00
Kymera Therapeutics (KYMR) United States $2.780B 0.00
Iovance Biotherapeutics (IOVA) United States $2.726B 0.00
Protagonist Therapeutics (PTGX) United States $2.655B 17.21
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.654B 0.00
Guardant Health (GH) United States $2.633B 0.00
IDEAYA Biosciences (IDYA) United States $2.610B 0.00
Geron (GERN) United States $2.610B 0.00
Twist Bioscience (TWST) United States $2.605B 0.00
Janux Therapeutics (JANX) United States $2.585B 0.00
Apogee Therapeutics (APGE) United States $2.562B 0.00
ImmunityBio (IBRX) United States $2.542B 0.00
Zai Lab (ZLAB) China $2.523B 0.00
Neumora Therapeutics (NMRA) United States $2.482B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.475B 82.89
Bavarian Nordic (BVNRY) Denmark $2.434B 13.02
CG Oncology (CGON) United States $2.421B 0.00
Vera Therapeutics (VERA) United States $2.342B 0.00
SpringWorks Therapeutics (SWTX) United States $2.278B 0.00
Keros Therapeutics (KROS) United States $2.243B 0.00
Structure Therapeutics (GPCR) United States $2.192B 0.00
Myriad Genetics (MYGN) United States $2.187B 0.00
Scholar Rock Holding (SRRK) United States $2.122B 0.00
Celldex Therapeutics (CLDX) United States $2.076B 0.00
Akero Therapeutics (AKRO) United States $2.057B 0.00
Vericel (VCEL) United States $2.044B 0.00
Beam Therapeutics (BEAM) United States $2.037B 0.00
Novavax (NVAX) United States $2.006B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.980B 17.86
Galapagos (GLPG) Belgium $1.964B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.914B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.892B 0.00
Intellia Therapeutics (NTLA) United States $1.887B 0.00
Ligand Pharmaceuticals (LGND) United States $1.881B 31.97
Certara (CERT) United States $1.842B 60.26
Arvinas (ARVN) United States $1.794B 0.00
MannKind (MNKD) United States $1.782B 64.80
NeoGenomics (NEO) United States $1.734B 0.00
NovoCure (NVCR) Jersey $1.704B 0.00
Fortrea Holdings (FTRE) United States $1.696B 52.58
Belite Bio (BLTE) United States $1.693B 0.00
Arcus Biosciences (RCUS) United States $1.680B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.628B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.557B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.555B 0.00
Nurix Therapeutics (NRIX) United States $1.522B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.513B 0.00
Viridian Therapeutics (VRDN) United States $1.510B 0.00
Spyre Therapeutics (SYRE) United States $1.461B 0.00
Kura Oncology (KURA) United States $1.424B 0.00
Disc Medicine (IRON) United States $1.419B 0.00
Dynavax Technologies (DVAX) United States $1.367B 94.82
Tarsus Pharmaceuticals (TARS) United States $1.358B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.257B 0.00
Travere Therapeutics (TVTX) United States $1.255B 0.00
Gyre Therapeutics (GYRE) United States $1.232B 0.00
Cogent Biosciences (COGT) United States $1.231B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.218B 0.00
ANI Pharmaceuticals (ANIP) United States $1.202B 16.33
Tyra Biosciences (TYRA) United States $1.159B 0.00
Praxis Precision Medicines (PRAX) United States $1.154B 0.00
Mesoblast (MESO) Australia $1.151B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.144B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.102B 0.00
WAVE Life Sciences (WVE) Singapore $1.074B 0.00
Vir Biotechnology (VIR) United States $1.037B 0.00
Bicara Therapeutics (BCAX) United States $1.005B 0.00
Applied Therapeutics (APLT) United States $0.984B 0.00
ArriVent BioPharma (AVBP) United States $0.948B 0.00
Cullinan Therapeutics (CGEM) United States $0.940B 0.00
Zymeworks (ZYME) United States $0.938B 0.00
Prothena (PRTA) Ireland $0.926B 0.00
CARGO Therapeutics (CRGX) United States $0.918B 0.00
AnaptysBio (ANAB) United States $0.911B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.899B 0.00
IGM Biosciences (IGMS) United States $0.890B 0.00
Sana Biotechnology (SANA) United States $0.888B 0.00
Castle Biosciences (CSTL) United States $0.864B 0.00
Liquidia Technologies (LQDA) United States $0.851B 0.00
MiMedx (MDXG) United States $0.838B 23.79
Pliant Therapeutics (PLRX) United States $0.830B 0.00
Dianthus Therapeutics (DNTH) United States $0.808B 0.00
Rapport Therapeutics (RAPP) United States $0.807B 0.00
Immatics (IMTX) Germany $0.791B 0.00
Replimune (REPL) United States $0.784B 0.00
Annexon (ANNX) United States $0.780B 0.00
Erasca (ERAS) United States $0.777B 0.00
89BIO (ETNB) United States $0.766B 0.00
AbCellera Biologics (ABCL) Canada $0.763B 0.00
MBX Biosciences (MBX) United States $0.763B 0.00
Pacira BioSciences (PCRX) United States $0.748B 7.08
BioAge Labs (BIOA) United States $0.741B 0.00
Tango Therapeutics (TNGX) United States $0.735B 0.00
Immunome (IMNM) United States $0.734B 0.00
Arbutus Biopharma (ABUS) United States $0.732B 0.00
Adaptive Biotechnologies (ADPT) United States $0.729B 0.00
Zenas BioPharma (ZBIO) United States $0.694B 0.00
Humacyte (HUMA) United States $0.684B 0.00
LENZ Therapeutics (LENZ) United States $0.679B 0.00
Mineralys Therapeutics (MLYS) United States $0.674B 0.00
Olema Pharmaceuticals (OLMA) United States $0.672B 0.00
Cytek Biosciences (CTKB) United States $0.659B 0.00
Avid Bioservices (CDMO) United States $0.658B 0.00
Oric Pharmaceuticals (ORIC) United States $0.658B 0.00
Astria Therapeutics (ATXS) United States $0.656B 0.00
CureVac (CVAC) Germany $0.651B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Neurogene (NGNE) United States $0.642B 0.00
Entrada Therapeutics (TRDA) United States $0.624B 5.67
Stoke Therapeutics (STOK) United States $0.623B 0.00
Oculis Holding AG (OCS) Switzerland $0.603B 0.00
Abivax SA (ABVX) France $0.603B 0.00
Q32 Bio (QTTB) United States $0.586B 0.00
CorMedix Inc (CRMD) United States $0.585B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.578B 0.00
Pharming Group (PHAR) Netherlands $0.577B 0.00
Nuvation Bio (NUVB) United States $0.566B 0.00
Celcuity (CELC) United States $0.561B 0.00
Allogene Therapeutics (ALLO) United States $0.554B 0.00
Revance Therapeutics (RVNC) United States $0.553B 0.00
Terns Pharmaceuticals (TERN) United States $0.539B 0.00
ACELYRIN, INC (SLRN) United States $0.538B 0.00
Third Harmonic Bio (THRD) United States $0.513B 0.00
REGENXBIO (RGNX) United States $0.489B 0.00
Alumis (ALMS) United States $0.489B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.481B 0.00
Cartesian Therapeutics (RNAC) United States $0.474B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.473B 0.00
PureTech Health (PRTC) United States $0.469B 0.00
Alector (ALEC) United States $0.467B 0.00
Emergent Biosolutions (EBS) United States $0.463B 0.00
Absci (ABSI) United States $0.462B 0.00
Tectonic Therapeutic (TECX) United States $0.462B 0.00
Anavex Life Sciences (AVXL) United States $0.456B 0.00
Aura Biosciences (AURA) United States $0.450B 0.00
GRAIL (GRAL) United States $0.450B 0.00
Prime Medicine (PRME) United States $0.437B 0.00
Contineum Therapeutics (CTNM) United States $0.433B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.428B 0.00
Foghorn Therapeutics (FHTX) United States $0.422B 0.00
MaxCyte (MXCT) United States $0.408B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.407B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.396B 0.00
Voyager Therapeutics (VYGR) United States $0.392B 25.64
Biomea Fusion (BMEA) United States $0.390B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.383B 0.00
C4 Therapeutics (CCCC) United States $0.379B 0.00
Anika Therapeutics (ANIK) United States $0.376B 181.29
Artiva Biotherapeutics (ARTV) United States $0.367B 0.00
Alto Neuroscience (ANRO) United States $0.365B 0.00
Climb Bio (CLYM) United States $0.363B 0.00
ITeos Therapeutics (ITOS) United States $0.363B 0.00
Nautilus Biotechnology (NAUT) United States $0.359B 0.00
GH Research (GHRS) Ireland $0.357B 0.00
Fate Therapeutics (FATE) United States $0.352B 0.00
AC Immune (ACIU) Switzerland $0.328B 0.00
Inozyme Pharma (INZY) United States $0.325B 0.00
XOMA Royalty (XOMA) United States $0.323B 0.00
EnGene Holdings (ENGN) Canada $0.318B 0.00
Sutro Biopharma (STRO) United States $0.311B 0.00
GENFIT S.A (GNFT) France $0.303B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.303B 0.00
Kamada (KMDA) Israel $0.302B 19.44
Prima BioMed (IMMP) Australia $0.300B 0.00
Opthea (OPT) Australia $0.300B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.298B 0.00
Urogen Pharma (URGN) United States $0.296B 0.00
Atea Pharmaceuticals (AVIR) United States $0.294B 0.00
Alpha Teknova (TKNO) United States $0.291B 0.00
PepGen (PEPG) United States $0.287B 0.00
TScan Therapeutics (TCRX) United States $0.286B 0.00
Ocugen (OCGN) United States $0.284B 0.00
Design Therapeutics (DSGN) United States $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.278B 0.00
MeiraGTx Holdings (MGTX) United States $0.276B 0.00
UniQure (QURE) Netherlands $0.275B 0.00
Nkarta (NKTX) United States $0.274B 0.00
Instil Bio (TIL) United States $0.274B 0.00
Zura Bio (ZURA) United States $0.273B 0.00
Compass Therapeutics (CMPX) United States $0.272B 0.00
ChromaDex (CDXC) United States $0.270B 0.00
Editas Medicine (EDIT) United States $0.263B 0.00
Rezolute (RZLT) United States $0.263B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
2seventy Bio (TSVT) United States $0.258B 0.00
Poseida Therapeutics (PSTX) United States $0.244B 0.00
Amarin (AMRN) Ireland $0.242B 0.00
Mersana Therapeutics (MRSN) United States $0.242B 0.00
Solid Biosciences (SLDB) United States $0.234B 0.00
Precigen (PGEN) United States $0.227B 0.00
XBiotech (XBIT) United States $0.227B 0.00
Jasper Therapeutics (JSPR) United States $0.227B 0.00
Kyverna Therapeutics (KYTX) United States $0.227B 0.00
Trevi Therapeutics (TRVI) United States $0.226B 0.00
Inhibrx Biosciences (INBX) United States $0.226B 0.00
Codexis (CDXS) United States $0.223B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.223B 0.00
Gossamer Bio (GOSS) United States $0.218B 0.00
Fulcrum Therapeutics (FULC) United States $0.217B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.213B 0.00
ScPharmaceuticals (SCPH) United States $0.212B 0.00
Eton Pharmaceuticals (ETON) United States $0.207B 0.00
Cabaletta Bio (CABA) United States $0.206B 0.00
Candel Therapeutics (CADL) United States $0.193B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.192B 0.00
Black Diamond Therapeutics (BDTX) United States $0.188B 0.00
DiaMedica Therapeutics (DMAC) United States $0.182B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
BioStem Technologies (BSEM) $0.178B 27.91
Sangamo Therapeutics (SGMO) United States $0.174B 0.00
Molecular Partners AG (MOLN) Switzerland $0.174B 0.00
Caribou Biosciences (CRBU) United States $0.172B 0.00
ATyr Pharma (ATYR) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Generation Bio (GBIO) United States $0.160B 0.00
Adverum Biotechnologies (ADVM) United States $0.159B 0.00
Compugen (CGEN) Israel $0.153B 0.00
Scilex Holding (SCLX) United States $0.151B 0.00
Ventyx Biosciences (VTYX) United States $0.151B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.151B 0.00
Kodiak Sciences (KOD) United States $0.149B 0.00
Inovio Pharmaceuticals (INO) United States $0.149B 0.00
Akoya Biosciences (AKYA) United States $0.149B 0.00
Actuate Therapeutics (ACTU) United States $0.144B 0.00
23andMe Holding (ME) United States $0.143B 0.00
Lifecore Biomedical (LFCR) United States $0.143B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.141B 0.00
Puma Biotechnology (PBYI) United States $0.140B 15.00
Tenaya Therapeutics (TNYA) United States $0.140B 0.00
Vigil Neuroscience (VIGL) United States $0.139B 0.00
Seres Therapeutics (MCRB) United States $0.137B 0.00
Repare Therapeutics (RPTX) Canada $0.133B 0.00
Sagimet Biosciences (SGMT) United States $0.132B 0.00
Skye Bioscience (SKYE) United States $0.130B 0.00
Immunic (IMUX) United States $0.126B 0.00
Elutia (ELUT) United States $0.126B 0.00
PDS Biotechnology (PDSB) United States $0.126B 0.00
Invivyd (IVVD) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
Seer (SEER) United States $0.122B 0.00
Adherex Technologies (FENC) United States $0.121B 110.50
Verastem (VSTM) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
Benitec Biopharma (BNTC) United States $0.115B 0.00
Adicet Bio (ACET) United States $0.115B 0.00
Coherus BioSciences (CHRS) United States $0.114B 0.00
Cellectis S.A (CLLS) France $0.112B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Rani Therapeutics Holdings (RANI) United States $0.108B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.106B 0.00
Genenta Science S.p.A (GNTA) Italy $0.106B 0.00
Annovis Bio (ANVS) United States $0.104B 0.00
I-Mab (IMAB) China $0.103B 0.00
INmune Bio (INMB) United States $0.102B 0.00
BioAtla (BCAB) United States $0.100B 0.00
Inventiva S.A (IVA) France $0.099B 0.00
Bluebird Bio (BLUE) United States $0.098B 0.00
Agenus (AGEN) United States $0.098B 0.00
BeyondSpring (BYSI) United States $0.097B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Oncolytics Biotech (ONCY) Canada $0.096B 0.00
Adagene (ADAG) China $0.094B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
FibroBiologics (FBLG) United States $0.091B 0.00
Genelux (GNLX) United States $0.090B 0.00
CytomX Therapeutics (CTMX) United States $0.090B 8.21
HilleVax (HLVX) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Werewolf Therapeutics (HOWL) United States $0.087B 0.00
MediciNova (MNOV) United States $0.087B 0.00
BioHarvest Sciences (CNVCF) Canada $0.087B 0.00
X4 Pharmaceuticals (XFOR) United States $0.086B 0.00
CervoMed (CRVO) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.082B 0.00
Ovid Therapeutics (OVID) United States $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.081B 0.00
ALX Oncology Holdings (ALXO) United States $0.081B 0.00
Chimerix (CMRX) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Renovaro (RENB) United States $0.080B 0.00
Aileron Therapeutics (ALRN) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.077B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Shattuck Labs (STTK) United States $0.074B 0.00
IO Biotech (IOBT) Denmark $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Spero Therapeutics (SPRO) United States $0.067B 3.05
Boundless Bio (BOLD) United States $0.067B 0.00
DBV Technologies S.A (DBVT) France $0.067B 0.00
Entera Bio (ENTX) Israel $0.067B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.065B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Semper Paratus Acquisition (TVGN) United States $0.065B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Rapt Therapeutics (RAPT) United States $0.064B 0.00
Kezar Life Sciences (KZR) United States $0.062B 0.00
Aerovate Therapeutics (AVTE) United States $0.061B 0.00
Imunon (IMNN) United States $0.061B 0.00
TELA Bio (TELA) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Leap Therapeutics (LPTX) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Allakos (ALLK) United States $0.058B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Kronos Bio (KRON) United States $0.056B 0.00
Celularity (CELU) United States $0.055B 0.00
Earth Science Tech (ETST) United States $0.055B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.053B 0.00
Omega Therapeutics (OMGA) United States $0.053B 0.00
Syros Pharmaceuticals (SYRS) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.052B 0.00
Aadi Bioscience (AADI) United States $0.050B 0.00
Lexaria Bioscience (LEXX) Canada $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.049B 0.00
Intensity Therapeutics (INTS) United States $0.046B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.046B 0.00
Vor Biopharma (VOR) $0.046B 0.00
Affimed (AFMD) Germany $0.046B 0.00
Rallybio (RLYB) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Immix Biopharma (IMMX) United States $0.040B 0.00
NextCure (NXTC) United States $0.040B 0.00
Atara Biotherapeutics (ATRA) United States $0.039B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
LakeShore Biopharma (LSB) China $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
Equillium (EQ) United States $0.033B 0.00
Ocuphire Pharma (OCUP) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
Curis (CRIS) United States $0.032B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Lumos Pharma (LUMO) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
Elevation Oncology (ELEV) United States $0.030B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Longeveron (LGVN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Aligos Therapeutics (ALGS) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
BioXcel Therapeutics (BTAI) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Biora Therapeutics (BIOR) United States $0.020B 0.00
HCW Biologics (HCWB) United States $0.019B 0.00
Monopar Therapeutics (MNPR) United States $0.019B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
Cadrenal Therapeutics (CVKD) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.014B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Apollomics (APLM) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Vincerx Pharma (VINC) United States $0.012B 0.00
Tenax Therapeutics (TENX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Carmell (CTCX) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Gritstone Bio (GRTS) United States $0.006B 0.00
ABVC BioPharma (ABVC) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
NuCana (NCNA) United Kingdom $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Virios Therapeutics (DWTX) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Vaccinex (VCNX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00